Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer nabs autoimmune disease drug rights for $25M upfront
Fierce Biotech
Monday, September 30, 2013 - 11:50am
tags:
Pfizer, autoimmune disease, GL-2045, Gliknik
What happens to the FDA in a government shutdown?
Fierce Biotech
Monday, September 30, 2013 - 11:46am
tags:
FDA
Welcome to the new face of big pharma marketing - under Obamacare, big brands can become household names
AdWeek
Monday, September 30, 2013 - 11:45am
tags:
healthcare reform, DTC, Big Pharma
Pfizer: An Analysis Using Warren Buffett's 10 Points Of Light
Seeking Alpha
Monday, September 30, 2013 - 11:41am
tags:
Pfizer
Abraxane's Approval for Pancreatic Cancer Is a Major Milestone for Celgene
Motley Fool
Monday, September 30, 2013 - 11:40am
tags:
Celgene, pancreatic cancer, Abraxane
KCI, LifeCell and Systagenix to Form One Company Focused on Transformational Healing Solutions under the Leadership of President & CEO Joe Woody
CP Wire
Monday, September 30, 2013 - 11:09am
tags:
KCI, LifeCell, Systagenix, M&A, wound care, devices
Bumpy road won't deter Sanofi's push into emerging markets
Reuters
Monday, September 30, 2013 - 10:55am
tags:
Sanofi, emerging markets, China, M&A
Bard, Vaginal-Mesh Makers, Said to Be in Settlement Talks
Bloomberg
Monday, September 30, 2013 - 10:52am
tags:
vaginal mesh, Bard, devices
What's Left Of Enzon Pharmaceuticals?
Seeking Alpha
Monday, September 30, 2013 - 10:48am
tags:
Enzon
Achillion Falls on FDA Hold on Hepatitis C Medicine
Bloomberg
Monday, September 30, 2013 - 10:47am
tags:
Achillion, FDA, hepatitis C, sovaprevir
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Yahoo
Monday, September 30, 2013 - 10:45am
tags:
FDA, orphan drugs, Omeros, OMS824, Huntington's disease
Amgen's 10 Billion Dollar Molecule
Seeking Alpha
Monday, September 30, 2013 - 10:44am
tags:
Amgen, Takeda, ONYX Pharmaceuticals, Kyprolis
These 2 Hepatitis-C Drug Developers Are Getting Left in the Dust
Motley Fool
Monday, September 30, 2013 - 10:41am
tags:
hepatitis C, Vertex Pharmaceuticals, Incivek, sovaprevir, Achillion, IDX184, IDX320, Idenix
Biogen, Isis Pharma And The Attraction Of The Orphan Drug Business
Seeking Alpha
Monday, September 30, 2013 - 10:38am
tags:
Biogen Idec, Isis Pharmaceuticals, orphan drugs, Kynamro, ISIS-DMPKRx
US demand for biosimilarity testing growing says specialist CRO
Outsourcing Pharma
Monday, September 30, 2013 - 10:36am
tags:
CROs, biosimilars
Bayer Chastised For Nightcaps After A Medical Conference
Pharmalot
Monday, September 30, 2013 - 10:35am
tags:
Bayer
GlaxoSmithKline to divest thrombosis assets to Aspen
Yahoo/Fly on the Wall
Monday, September 30, 2013 - 10:34am
tags:
GSK, Aspen Group, thrombosis, Arixtra, Fraxiparine
AstraZeneca CEO gets two cheers after first year in job
Yahoo/Reuters
Monday, September 30, 2013 - 10:32am
tags:
Pharma CEOs, AstraZeneca, Pascal Soriot
Bayer appoints Pfizer's Brandicourt as head of healthcare
Yahoo/Reuters
Monday, September 30, 2013 - 10:32am
tags:
Bayer, Pfizer
With Promising Results, AstraZeneca Targets Mutated Lung Cancer And Rival Clovis Drug
TheStreet.com
Monday, September 30, 2013 - 10:31am
tags:
AZD9291, Clovis Oncology, AstraZeneca, CO-1686, non-small cell lung cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.